SEC Company Response from VOLITIONRX LTD (VNRX) (CIK 0000093314) (VNRX) — Jun 24, 2015
VOLITIONRX LTD (VNRX) (CIK 0000093314)
Date: June 24, 2015 · CIK: 0000093314 · Accession: 0001078782-15-001006
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-195213
Letter
Acceleration Request
June 24, 2015
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Christina De Rosa
Re:
VolitionRX Limited
Post-Effective Amendment No. 1 to Form S-1 on Form S-3
Filed June 12, 2015
File No. 333-195213
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, VolitionRX Limited (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate of the effective date of the above-mentioned post-effective amendment on Form S-3, so that it may become effective at 4:30 p.m. Eastern Time on June 26, 2015, or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
·
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
·
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
·
the Company may not assert the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Thank you for your assistance and cooperation with this matter.
Very truly yours,
VolitionRX Limited
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request June 24, 2015 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Christina De Rosa Re: VolitionRX Limited Post-Effective Amendment No. 1 to Form S-1 on Form S-3 Filed June 12, 2015 File No. 333-195213 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, VolitionRX Limited (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate of the effective date of the above-mentioned post-effective amendment on Form S-3, so that it may become effective at 4:30 p.m. Eastern Time on June 26, 2015, or as soon thereafter as practicable. The Registrant hereby acknowledges that: · should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; · the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and · the Company may not assert the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Thank you for your assistance and cooperation with this matter. Very truly yours, VolitionRX Limited By: /s/ Cameron Reynolds Cameron Reynolds President and Principal Executive Officer